CAMALLERGY

Camallergy (Cambridge Allergy Ltd) is a biopharmaceutical company dedicated to providing innovative, patient-centric treatments to address the millions of patients suffering worldwide from food allergies. Camallergy’s lead product, CA002, is a second-generation novel oral immunotherapy for the treatment of peanut allergy designed to offer “bite-proof” protection to patients within 14 weeks of therapy. The Company’s unique intellectual property and treatment regimen are based on the clinical work initiated at Cambridge University Hospitals NHS Foundation Trust in Cambridge, UK.

#People #Financial #Website #More

CAMALLERGY

Industry:

Biotechnology Clinical Trials Health Care Therapeutics

Founded:

2015-01-01

Address:

Cambridge, Cambridgeshire, United Kingdom

Country:

United Kingdom

Website Url:

http://www.camallergy.com

Total Employee:

Status:

Active

Email Addresses:

[email protected]

Total Funding:

1.92 M GBP

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Global Site Tag Amazon Pound Sterling Typekit